Artificial Intelligence-Guided Extracellular Vesicle Platforms for Diagnosis and Treatment of Chronic Kidney Disease: A Scoping Review and Future Directions
Background and Objectives: Chronic kidney disease (CKD) affects roughly 788 million adults worldwide according to the Global Burden of Disease (GBD) 2023 estimate. Extracellular vesicles (EVs) are promising sources of biomarkers and therapeutic carriers, while artificial intelligence (AI) offers tools for high-dimensio...